MANUEL
DELGADO ALVARADO
Investigador hasta 2022
Universidad de Cantabria
Santander, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Cantabria (13)
2023
-
A novel clinical sign to assess the risk of Parkinson’s disease in patients with isolated asymmetric arm swing
Neurological Sciences, Vol. 44, Núm. 4, pp. 1401-1404
-
Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study
Frontiers in Immunology, Vol. 14
2022
2021
-
Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge
British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278
-
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study
Frontiers in Immunology, Vol. 12
-
Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease
Frontiers in Neurology, Vol. 12
-
Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8 years’ follow-up
European Journal of Neurology, Vol. 28, Núm. 12, pp. 4204-4208
2020
-
A novel SGCE variant is associated with myoclonus-dystonia with phenotypic variability
Neurological Sciences, Vol. 41, Núm. 12, pp. 3779-3781
-
Nonpharmacological, nonsurgical treatments for freezing of gait in Parkinson's disease: A systematic review
Movement Disorders, Vol. 35, Núm. 2, pp. 204-214
2016
-
Patrón geográfico de la mortalidad por enfermedad de Parkinson en España y su asociación con los niveles de plomo en el aire
Medicina Clinica, Vol. 147, Núm. 11, pp. 481-487
-
Trends in motor neuron disease: association with latitude and air lead levels in Spain
Neurological Sciences, Vol. 37, Núm. 8, pp. 1271-1275
2013
-
Clinical spectrum of peripheral facial paralysis in HIV-infected patients according to HIV status
International Journal of STD and AIDS, Vol. 24, Núm. 1, pp. 39-41